Baird analyst Michael Ha lowered the firm’s price target on Centene (CNC) to $69 from $71 and keeps a Neutral rating on the shares. The firm ...

Centene Corp. closed 21.81% below its 52-week high of $80.59, which the company achieved on September 3rd.

StoneCo's stock is up 37% in 2025, with robust growth and low valuations offering 38% upside potential. Read why I rate STNE a Strong Buy.

StoneCo's Brazilian focus and lack of regional diversification protect it from U.S. tariffs. Read why I think STNE stock is a ...

Saint Louis, Missouri-based Centene Corporation (CNC) operates as a healthcare enterprise, providing programs and services to ...

Centene Corp. closed 20.76% short of its 52-week high of $80.59, which the company achieved on September 3rd.

We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Centene (CNC – Research Report), with a price target of ...

US Stock Market on March 12: The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite indices eked out mild gains amid choppy trade on Wednesday, in some respite for Wall Street bulls ...